SCHEMBL31436039

SCHEMBL31436039

CC(C)(C)OC(=O)NCCCOc1nc(Cl)nc(OCCCNC(=O)OC(C)(C)C)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.57
STK17A Q9UEE5 1/20 0.57
CA12 O43570 7/20 0.50
CA1 P00915 7/20 0.50
CA2 P00918 7/20 0.50
CA9 Q16790 7/20 0.50
TDP1 Q9NUW8 2/20 0.48
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
DRD2 P14416 4/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP1A1 P04798 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP3A43 Q9HB55 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31681549 0.84 STK17B (0.46) STK17BSTK17ACA12CA1CA2
SCHEMBL17563634 0.80 STK17B (0.47) STK17BSTK17ACA12CA1CA2
SCHEMBL24554752 0.79 STK17B (0.49) STK17BSTK17ACA12CA1CA2
SCHEMBL31436047 0.77 STK17B (0.43) STK17BSTK17ACA12CA1CA2
SCHEMBL16450757 0.76 CA12 (0.64) STK17BSTK17ACA12CA1CA2
SCHEMBL31436059 0.76 STK17B (0.62) STK17BSTK17ACA12CA1CA2
SCHEMBL17564533 0.76 STK17B (0.62) STK17BSTK17ACA12CA1CA2
SCHEMBL27002762 0.76 CA12 (0.55) STK17BSTK17ACA12CA1CA2
SCHEMBL22917487 0.76 STK17B (0.49) STK17BSTK17ACA12CA1CA2
SCHEMBL17564591 0.76 STK17B (0.46) STK17BSTK17ACA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025088570-A1 IONIZABLE LIPIDS AND IONIZABLE LIPID NANOPARTICLES CRISPR THERAPEUTICS AG (CH) 2025-05-01 WO disclosed